z-logo
Premium
Photodynamic therapy for esophageal cancer using a 180° windowed esophageal balloon
Author(s) -
Overholt Bergein F.,
Panjehpour Masoud,
Denovo Robert C.,
Petersen Mark G.
Publication year - 1994
Publication title -
lasers in surgery and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 112
eISSN - 1096-9101
pISSN - 0196-8092
DOI - 10.1002/lsm.1900140109
Subject(s) - photodynamic therapy , balloon , esophageal cancer , medicine , esophagus , photosensitizer , radiology , biomedical engineering , cancer , surgery , physics , chemistry , organic chemistry , quantum mechanics
Abstract Although delivery of uniform circumferential light is desirable during photodynamic therapy of advanced esophageal cancer in humans, early esophageal cancer may need only targeted treatment. Studies were performed in the canine esophagus of eight animals to investigate whether use of a “windowed” (shaded) centering balloon would improve targeted illumination of esophageal mucosa for photodynamic therapy. Shaded balloons were developed with a 2‐cm‐long, 360° or 180° clear “window.” Photofrin 4 mg/Kg was used as the photosensitizer. Light at 630 nm was delivered at 300 J/cm or 600 J/cm. Isotropic probes placed on the balloon wall allowed real‐time measurement and verification of relatively uniform light doses delivered to esophageal mucosa during balloon photodynamic therapy. With the windowed balloon, targeted delivery of photodynamic therapy was possible. Using the 180° balloon, mucosa exposed to illumination was destroyed, whereas mucosa protected from light by the balloon shading was undamaged. Healing was complete and strictures did not occur. The shading of the balloon protected normal mucosa and prevents the formation of esophageal strictures. The “windowed” centering balloon provides a technology and technique that allows targeted delivery of uniform light during esophageal PDT. © 1994 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here